Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -47.833% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] Cc1cc(C)n(C(=O)CNC(=O)c2ccco2)n1
[b] O=C(COc1ccc(Br)cc1CNCCCN1CCOCC1)Nc1ccccc1
[c] Cc1ccnn1CC(=O)N/N=C/c1cccs1
[d] Cl.Nc1ccc(Cc2ccccn2)cc1
Answer: b. O=C(COc1ccc(Br)cc1CNCCCN1CCOCC1)Nc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(COc1ccc(Br)cc1CNCCCN1CCOCC1)Nc1ccccc1
O=C(COc1ccc(Br)cc1CNCCCN1CCOCC1)Nc1ccccc1
2-[4-bromo-2-[(3-morpholin-4-ylpropylamino)methyl]phenoxy]-N-phenylacetamide